Immunic Inc. (IMUX) NASDAQ

$5.18 0.09 (1.77%)

Market Cap: $155.58M

As of 08/17/22 09:45 AM EDT. Market open.

(IMUX)

Immunic Inc. (IMUX) NASDAQ

$5.18 0.09 (1.77%)

Market Cap: $155.58M

As of 08/17/22 09:45 AM EDT. Market open.

Immunic, Inc. is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn's disease, and psoriasis. Immunic is developing three small molecule products: its lead development program, IMU-838, is a selective immune ... read more

Immunic, Inc. is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn's disease, and psoriasis. Immunic is developing three small molecule products: its lead development program, IMU-838, is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH and exhibits a host-based antiviral effect; IMU-935 is an inverse agonist of ROR?t; and IMU-856 targets the restoration of the intestinal barrier function. Immunic announced positive results from its phase 2 EMPhASIS trial of IMU-838 in patients with relapsing-remitting multiple sclerosis, reporting achievement of both primary and key secondary endpoints with high statistical significance. IMU-838 is also in phase 2 clinical development for ulcerative colitis and COVID-19, with an additional phase 2 trial considered in Crohn's disease. An investigator-sponsored proof-of-concept clinical trial for IMU-838 in primary sclerosing cholangitis is ongoing at the Mayo Clinic. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Daniel Vitt
Full Time Employees
28
URL
Address
Am Klopferspitz 19, Bayern, Martinsried, 82152.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Daniel Vitt
Full Time Employees
28
Address
Am Klopferspitz 19, Bayern, Martinsried, 82152.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$5.10
Previous Close
$5.09
Days Range
$4.93 - $5.52
52 week range
$2.52 - $14.50
Volume
6,069
Avg. Volume (30 days)
148,535
Market Cap
$155.58M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,564,995
Open
$5.10
Previous Close
$5.09
Days Range
$4.93 - $5.52
52 week range
$2.52 - $14.50
Volume
6,069
Avg. Volume (30 days)
148,535
Market Cap
$155.58M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,564,995

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IMMUNIC INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Vitt Daniel President and CEO Jun 03, 2022 Buy $3.10 5,000 15,500 368,877 Jun 06, 2022, 08:31 AM
Whaley Glenn Chief Financial Officer Jun 03, 2022 Buy $3.05 3,500 10,658 12,568 Jun 06, 2022, 08:31 AM
Muehler Andreas Chief Medical Officer May 12, 2022 Buy $5.10 3,500 17,850 297,986 May 16, 2022, 08:30 AM
Whaley Glenn Chief Financial Officer May 12, 2022 Buy $5.08 3,000 15,240 9,068 May 13, 2022, 08:31 AM
Nash Duane Executive Chairman May 12, 2022 Buy $5.03 10,000 50,300 22,032 May 13, 2022, 08:31 AM
Whaley Glenn PFO and PAO Aug 10, 2021 Buy $9.85 1,500 14,775 3,500 Aug 11, 2021, 09:05 AM
Vitt Daniel President and CEO Aug 10, 2021 Buy $9.60 1,000 9,600 363,877 Aug 11, 2021, 09:04 AM
Nash Duane Executive Chairman Aug 10, 2021 Buy $9.80 1,000 9,800 15,032 Aug 11, 2021, 09:02 AM
Nash Duane Executive Chairman May 12, 2021 Buy $12.75 4,000 51,000 14,032 May 12, 2021, 04:31 PM
Muehler Andreas Chief Medical Officer Mar 02, 2021 Buy $15.54 10,006 155,493 294,486 Mar 15, 2021, 05:05 PM
Whaley Glenn PFO and PAO Mar 02, 2021 Buy $16.48 1,000 16,480 2,000 Mar 03, 2021, 04:31 PM
Whaley Glenn PFO and PAO Aug 10, 2020 Buy $18.96 1,000 18,960 1,000 Aug 10, 2020, 05:15 PM
Groeppel Manfred Chief Operating Officer Jul 20, 2020 Sale $14.44 5,000 72,200 279,480 Jul 22, 2020, 04:06 PM
Groeppel Manfred Chief Operating Officer Jul 21, 2020 Sale $15.62 650 10,155 278,830 Jul 22, 2020, 04:06 PM
Vitt Daniel Chief Executive Officer Jul 21, 2020 Sale $15.62 1,300 20,310 362,877 Jul 22, 2020, 04:05 PM
Vitt Daniel Chief Executive Officer Jul 20, 2020 Sale $14.44 5,000 72,200 364,177 Jul 22, 2020, 04:05 PM
Nash Duane Director Dec 03, 2019 Option Exercise $7.15 7,930 56,732 14,432 Dec 04, 2019, 07:00 PM
Nash Duane Director Dec 04, 2019 Sale $6.96 4,400 30,624 10,032 Dec 04, 2019, 07:00 PM
Halperin Errol R. Director Sep 25, 2018 Sale $0.29 89,417 25,940 0 Sep 25, 2018, 07:28 PM
Halperin Errol R. Director Sep 25, 2018 Sale $0.29 10,000 2,900 0 Sep 25, 2018, 07:28 PM
BIENAIME JEAN JACQUES Director Sep 24, 2018 Sale $0.30 26,619 8,002 18,500 Sep 24, 2018, 07:24 PM
Godshall Douglas Evan Director Sep 19, 2018 Sale $0.35 69,375 24,191 0 Sep 21, 2018, 04:19 PM
Satter Muneer A Director Sep 13, 2018 Sale $0.50 3,890,000 1,930,996 7,492,277 Sep 17, 2018, 09:30 PM
Satter Muneer A Director Sep 17, 2018 Sale $0.29 7,044,777 2,054,257 0 Sep 17, 2018, 09:30 PM
Satter Muneer A Director Sep 14, 2018 Sale $0.36 447,500 160,384 7,044,777 Sep 17, 2018, 09:30 PM
Hasnain Faheem Director Sep 13, 2018 Sale $0.44 177,443 77,679 122,743 Sep 17, 2018, 09:26 PM
BIENAIME JEAN JACQUES Director Sep 13, 2018 Sale $0.47 20,000 9,400 45,119 Sep 17, 2018, 09:24 PM
Cohen Cheryl Director Sep 12, 2018 Sale $0.55 3,500 1,925 0 Sep 14, 2018, 04:08 PM
Satter Muneer A Director Dec 12, 2017 Buy $5.40 50,000 269,765 11,332,277 Dec 14, 2017, 06:47 PM
Satter Muneer A Director Dec 13, 2017 Buy $5.57 50,000 278,570 11,382,277 Dec 14, 2017, 06:47 PM
Satter Muneer A Director Dec 11, 2017 Buy $4.96 50,000 248,225 11,282,277 Dec 11, 2017, 05:35 PM
Satter Muneer A Director Dec 08, 2017 Buy $4.92 50,000 246,185 11,232,277 Dec 11, 2017, 05:35 PM
Satter Muneer A Director Dec 07, 2017 Buy $4.77 50,000 238,730 11,182,277 Dec 11, 2017, 05:35 PM
Hasnain Faheem Director Sep 14, 2017 Buy $4.19 59,200 247,870 181,943 Sep 15, 2017, 04:19 PM
Satter Muneer A Director Sep 13, 2017 Buy $4.13 50,000 206,465 11,102,277 Sep 14, 2017, 07:40 PM
Satter Muneer A Director Sep 12, 2017 Buy $3.74 50,000 187,225 11,052,277 Sep 14, 2017, 07:40 PM
Satter Muneer A Director Sep 14, 2017 Buy $4.25 30,000 127,539 11,132,277 Sep 14, 2017, 07:40 PM
BIENAIME JEAN JACQUES Director Sep 13, 2017 Buy $4.00 10,000 39,969 65,119 Sep 14, 2017, 04:15 PM
Satter Muneer A Director Sep 08, 2017 Buy $3.53 50,000 176,615 11,002,277 Sep 12, 2017, 04:14 PM
DUNN JOHN MICHAEL General Counsel and Secretary Jun 14, 2017 Buy $3.09 2,500 7,724 11,885 Jun 15, 2017, 04:29 PM
Winters Terence E. Co-Chairman and CEO Jun 14, 2017 Buy $3.10 10,000 30,981 194,966 Jun 15, 2017, 04:28 PM
BIENAIME JEAN JACQUES Director Jun 13, 2017 Buy $3.00 16,000 48,069 55,119 Jun 15, 2017, 04:27 PM
Satter Muneer A Director Jun 14, 2017 Buy $3.10 10,000 31,008 10,952,277 Jun 14, 2017, 05:13 PM
Satter Muneer A Director Jun 13, 2017 Buy $3.03 10,000 30,311 10,942,277 Jun 14, 2017, 05:13 PM
Ashley Robert A. Chief Technical Officer, EVP Jun 09, 2017 Buy $3.18 2,000 6,360 2,000 Jun 13, 2017, 08:05 PM
Satter Muneer A Director Jun 12, 2017 Buy $3.06 10,000 30,615 10,932,277 Jun 12, 2017, 04:05 PM
Satter Muneer A Director Jun 09, 2017 Buy $3.17 10,000 31,733 10,922,277 Jun 12, 2017, 04:05 PM
Satter Muneer A Director Jun 08, 2017 Buy $3.10 10,000 30,958 10,912,277 Jun 12, 2017, 04:05 PM
Nash Duane President Jun 08, 2017 Buy $3.12 3,900 12,182 8,224 Jun 09, 2017, 04:06 PM
Satter Muneer A Director Jun 07, 2017 Buy $3.21 10,000 32,074 10,902,277 Jun 07, 2017, 07:15 PM
Satter Muneer A Director Jun 06, 2017 Buy $3.19 10,000 31,940 10,892,277 Jun 07, 2017, 07:15 PM
Satter Muneer A Director Mar 27, 2017 Buy $4.00 3,750,000 15,000,000 10,882,277 Mar 27, 2017, 06:02 PM
Hasnain Faheem Director Aug 12, 2016 Buy $5.92 118,243 699,999 122,743 Aug 15, 2016, 09:23 AM
Satter Muneer A Director Oct 28, 2015 Buy $5.50 400,000 2,200,000 7,132,277 Oct 29, 2015, 04:09 PM
DUNN JOHN MICHAEL General Counsel and Secretary Oct 26, 2015 Buy $7.00 2,000 14,000 9,385 Oct 27, 2015, 08:26 PM
DUNN JOHN MICHAEL General Counsel and Secretary Oct 23, 2015 Buy $6.76 7,385 49,933 7,385 Oct 27, 2015, 08:26 PM
Cohen Cheryl Director Oct 26, 2015 Buy $7.17 3,500 25,090 3,500 Oct 27, 2015, 06:57 PM
Winters Terence E. Co-Chairman and CEO Sep 14, 2015 Option Exercise $0.43 128,394 55,004 190,566 Sep 16, 2015, 04:11 PM
BIENAIME JEAN JACQUES Director Sep 09, 2015 Buy $3.10 8,000 24,800 33,119 Sep 11, 2015, 12:47 PM
BIENAIME JEAN JACQUES Director Sep 10, 2015 Buy $3.05 6,000 18,293 39,119 Sep 11, 2015, 12:47 PM
Winters Terence E. Co-Chairman and CEO Oct 10, 2014 Buy $14.86 1,360 20,203 184,442 Oct 14, 2014, 07:29 PM
Nash Duane See Remarks Oct 08, 2014 Buy $17.50 100 1,750 9,324 Oct 09, 2014, 09:09 PM
BIENAIME JEAN JACQUES Director Oct 08, 2014 Buy $17.50 4,286 75,005 25,119 Oct 09, 2014, 09:07 PM
Halperin Errol R. Director Oct 08, 2014 Buy $17.50 1,667 29,173 10,000 Oct 09, 2014, 09:05 PM
Halperin Errol R. Director Oct 08, 2014 Buy $17.50 3,809 66,658 89,417 Oct 09, 2014, 09:05 PM
Godshall Douglas Evan Director Oct 08, 2014 Buy $17.50 2,857 49,998 69,375 Oct 09, 2014, 09:03 PM
Satter Muneer A Director Oct 08, 2014 Buy $17.50 74,286 1,300,005 6,732,277 Oct 09, 2014, 09:02 PM
SEARS LOWELL Director Oct 08, 2014 Buy $17.50 1,429 25,008 58,572 Oct 09, 2014, 09:01 PM
Satter Muneer A Director Jun 03, 2014 Buy $14.01 6,600 92,456 6,657,985 Jun 04, 2014, 07:41 PM
Satter Muneer A Director Jun 02, 2014 Buy $12.45 7,900 98,355 6,651,385 Jun 04, 2014, 07:41 PM
Satter Muneer A Director Apr 23, 2014 Buy $12.00 360,966 4,331,592 6,643,485 Apr 23, 2014, 07:51 PM
CROXFORD PHILIP M Director Apr 23, 2014 Buy $12.00 1,500 18,000 17,841 Apr 23, 2014, 07:19 PM
SEARS LOWELL Director Apr 23, 2014 Buy $12.00 12,500 150,000 12,500 Apr 23, 2014, 07:18 PM
Halperin Errol R. Director Apr 23, 2014 Buy $12.00 6,191 74,292 6,191 Apr 23, 2014, 07:14 PM
Halperin Errol R. Director Apr 23, 2014 Buy $12.00 8,333 99,996 8,333 Apr 23, 2014, 07:14 PM
Godshall Douglas Evan Director Apr 23, 2014 Buy $12.00 12,500 150,000 12,500 Apr 23, 2014, 07:13 PM
BIENAIME JEAN JACQUES Director Apr 23, 2001 Buy $12.00 8,333 99,996 8,333 Apr 23, 2014, 07:08 PM
Stern Aron See Remarks Apr 23, 2014 Buy $12.00 83 996 1,333 Apr 23, 2014, 07:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Vitt Daniel President and CEO 06/03/2022 15,500
Whaley Glenn Chief Financial Officer 06/03/2022 10,658
Muehler Andreas Chief Medical Officer 05/12/2022 17,850
Whaley Glenn Chief Financial Officer 05/12/2022 15,240
Nash Duane Executive Chairman 05/12/2022 50,300
Whaley Glenn PFO and PAO 08/10/2021 14,775
Vitt Daniel President and CEO 08/10/2021 9,600
Nash Duane Executive Chairman 08/10/2021 9,800
Nash Duane Executive Chairman 05/12/2021 51,000
Muehler Andreas Chief Medical Officer 03/02/2021 155,493
Whaley Glenn PFO and PAO 03/02/2021 16,480
Whaley Glenn PFO and PAO 08/10/2020 18,960
Groeppel Manfred Chief Operating Officer 07/20/2020 72,200
Groeppel Manfred Chief Operating Officer 07/21/2020 10,155
Vitt Daniel Chief Executive Officer 07/21/2020 20,310
Vitt Daniel Chief Executive Officer 07/20/2020 72,200
Nash Duane Director 12/03/2019 56,732
Nash Duane Director 12/04/2019 30,624
Halperin Errol R. Director 09/25/2018 25,940
Halperin Errol R. Director 09/25/2018 2,900
BIENAIME JEAN JACQUES Director 09/24/2018 8,002
Godshall Douglas Evan Director 09/19/2018 24,191
Satter Muneer A Director 09/13/2018 1,930,996
Satter Muneer A Director 09/17/2018 2,054,257
Satter Muneer A Director 09/14/2018 160,384
Hasnain Faheem Director 09/13/2018 77,679
BIENAIME JEAN JACQUES Director 09/13/2018 9,400
Cohen Cheryl Director 09/12/2018 1,925
Satter Muneer A Director 12/12/2017 269,765
Satter Muneer A Director 12/13/2017 278,570
Satter Muneer A Director 12/11/2017 248,225
Satter Muneer A Director 12/08/2017 246,185
Satter Muneer A Director 12/07/2017 238,730
Hasnain Faheem Director 09/14/2017 247,870
Satter Muneer A Director 09/13/2017 206,465
Satter Muneer A Director 09/12/2017 187,225
Satter Muneer A Director 09/14/2017 127,539
BIENAIME JEAN JACQUES Director 09/13/2017 39,969
Satter Muneer A Director 09/08/2017 176,615
DUNN JOHN MICHAEL General Counsel and Secretary 06/14/2017 7,724
Winters Terence E. Co-Chairman and CEO 06/14/2017 30,981
BIENAIME JEAN JACQUES Director 06/13/2017 48,069
Satter Muneer A Director 06/14/2017 31,008
Satter Muneer A Director 06/13/2017 30,311
Ashley Robert A. Chief Technical Officer, EVP 06/09/2017 6,360
Satter Muneer A Director 06/12/2017 30,615
Satter Muneer A Director 06/09/2017 31,733
Satter Muneer A Director 06/08/2017 30,958
Nash Duane President 06/08/2017 12,182
Satter Muneer A Director 06/07/2017 32,074
Satter Muneer A Director 06/06/2017 31,940
Satter Muneer A Director 03/27/2017 15,000,000
Hasnain Faheem Director 08/12/2016 699,999
Satter Muneer A Director 10/28/2015 2,200,000
DUNN JOHN MICHAEL General Counsel and Secretary 10/26/2015 14,000
DUNN JOHN MICHAEL General Counsel and Secretary 10/23/2015 49,933
Cohen Cheryl Director 10/26/2015 25,090
Winters Terence E. Co-Chairman and CEO 09/14/2015 55,004
BIENAIME JEAN JACQUES Director 09/09/2015 24,800
BIENAIME JEAN JACQUES Director 09/10/2015 18,293
Winters Terence E. Co-Chairman and CEO 10/10/2014 20,203
Nash Duane See Remarks 10/08/2014 1,750
BIENAIME JEAN JACQUES Director 10/08/2014 75,005
Halperin Errol R. Director 10/08/2014 29,173
Halperin Errol R. Director 10/08/2014 66,658
Godshall Douglas Evan Director 10/08/2014 49,998
Satter Muneer A Director 10/08/2014 1,300,005
SEARS LOWELL Director 10/08/2014 25,008
Satter Muneer A Director 06/03/2014 92,456
Satter Muneer A Director 06/02/2014 98,355
Satter Muneer A Director 04/23/2014 4,331,592
CROXFORD PHILIP M Director 04/23/2014 18,000
SEARS LOWELL Director 04/23/2014 150,000
Halperin Errol R. Director 04/23/2014 74,292
Halperin Errol R. Director 04/23/2014 99,996
Godshall Douglas Evan Director 04/23/2014 150,000
BIENAIME JEAN JACQUES Director 04/23/2001 99,996
Stern Aron See Remarks 04/23/2014 996
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
03/31/2022
1.99%
1Q
06/30/2022
12/31/2021
21.28%
2Q
06/30/2022
09/30/2021
33.06%
3Q
06/30/2022
06/30/2021
33.65%
4Q
06/30/2022
03/31/2021
35.48%
5Q
06/30/2022
03/31/2019
-34.38%
13Q
06/30/2022
12/31/2018
-32.29%
14Q
06/30/2022
09/30/2018
-32.29%
15Q
Load More

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2022
1.99%
1Q
12/31/2021
21.28%
2Q
09/30/2021
33.06%
3Q
06/30/2021
33.65%
4Q
03/31/2021
35.48%
5Q
03/31/2019
-34.38%
13Q
12/31/2018
-32.29%
14Q
09/30/2018
-32.29%
15Q
Load More